Got the post #CCRDownUnder blues? Listen to our interview and deep dive of the RSI trial with @JonathanCaseyMD, recently published in @NEJM
https://t.co/gx5awpNrI1
We are LIVE @ Critical Care Bootcamp 2025! Thank you to conference organizers for inviting us and thank you to everyone who came out to listen! We talk about the PIC trial by Lemiale et al published in @LancetRespirMed
PIC: https://t.co/OEAyjH39zi
🎧https://t.co/qPyhTM2Rd4
Episode 72! We continue talking about CCR25 with UK-ROX and and TARGET-Protein published in @JAMA_current and presented at the #CCR25 conference
UK-ROX: https://t.co/d42aH3Tvzl
TARGET-Protein: https://t.co/KSQLVH0AVv
🎧: https://t.co/qPyhTM2Rd4
Episode 71! We talk about FLUID published in @NEJM and BICAR-ICU from @TheLancet
FLUID: https://t.co/86g3gBtzve
BICAR-ICU: https://t.co/pZa3MAFhsX
🎧https://t.co/qPyhTM3p2C
Episode 70! We have @WesElyMD join us to talk about A2B by Walsh et al published in @JAMA_current May with the @ATSBlueEditor conference. Don't miss this one!
🎧https://t.co/qPyhTM2Rd4
A2B: https://t.co/9cj1gAbpVf
JAMA: https://t.co/xxPvwn0WMq
Editorial: https://t.co/J8hslNJOGt
Episode 69! We talk about the articles from the #CCR25 conference with RESCUE-3 published in @ATSBlueEditor by Dres et al and PROMIZING by Bosma et al in @NEJM
RESCUE-3: https://t.co/Xfldl0gEuz
PROMIZING: https://t.co/4Tw8tEMdVx
Listen: https://t.co/qPyhTM3p2C
Episode 68! Today we talk about modes of mechanical ventilation with the first author Dr. Kevin Seitz. This was published in @accpchest April of 2025
🎧: https://t.co/qPyhTM3p2C
Pubmed: https://t.co/rcZ72sB4Xp
Episode 66! We talk about Acute Chest Syndrome in Sickle Cell with one of our favorite hematologists, Benjamin Tillman! We base our discussion around the TASC trial published by Dessap et al in @ATSBlueEditor 2025.
Pubmed: https://t.co/9KSw0dwLph
🎧 https://t.co/qPyhTM3p2C
Episode 64! We talk more about steroids in severe CAP with "Effect of hydrocortisone on mortality in patients with severe community-acquired pneumonia : The REMAP-CAP Corticosteroid Domain Randomized Clinical Trial" published in ICM in 2025.
pubmed: https://t.co/r5uE6eANsV
Episode 63! We talk about thrombolysis in intermediate risk PE with PEERLESS published in @CircAHA and then PEITHO from @NEJM from 2014
PEERLESS: https://t.co/E5gpiRUm0q
PEITHO: https://t.co/M7s7gsklT0
PE Meta-analysis: https://t.co/lpYdrqf4qY
🎧https://t.co/qPyhTM2Rd4
Episode 62! We talk about some of the articles from the ISICEM conference and talk in depth about SESAR published in @JAMA_current with the conference last month!
🎧https://t.co/qPyhTM2Rd4
SESAR (pubmed): https://t.co/OwNL3m30F1
SESAR (JAMA): https://t.co/eLZZlfZQq6
Episode 61! We talk about HFNC including extubation to and how to wean it! Also, what do you think of when you think "auto-PEEP"?
🎧https://t.co/qPyhTM2Rd4
Auto-PEEP: https://t.co/9AaJTEk8aS
Extubate to HFNC: https://t.co/j6JrL4lObV
Weaning HFNC: https://t.co/t17I7gsbJq
#59! We talk about TRAUMAOX2 (@JAMA_current), SAHARA (@NEJM), and answer some listener questions finishing our #ccrdownunder coverage. Great discussions!
TRAUMOX2: https://t.co/7vCDBcvZ2J
SAHARA: https://t.co/mdhM0YRgRv
🎧anywhere: https://t.co/qPyhTM3p2C
#58! We talk about RENOVATE or "High-Flow Nasal Oxygen vs Noninvasive Ventilation in Patients With Acute Respiratory Failure" published
@JAMA_current and presented #ccrdownunder. We pair with FLORALI!
🎧anywhere: https://t.co/qPyhTM2Rd4
JAMA: https://t.co/7La1nflQIr
Episode 57! We were excited to have @adamatw PhD in Bioinformatics to discuss SCREEN published by Arabi et al in JAMA 2024 and presented at #CCRDownUnder. A long episode but a lot of good discussion
SCREEN: https://t.co/F97bRhTODm
Listen anywhere: https://t.co/rjPVmxdagw
#56! We talk about ADAPT-Sepsis or "Biomarker-Guided Antibiotic Duration for Hospitalized Patients With Suspected Sepsis" published in @JAMA_current and presented at #ccrdownunder
🎧anywhere: https://t.co/qPyhTM3p2C
Pubmed: https://t.co/OIKNWxi6do
JAMA: https://t.co/2G8FrN9oWM
Episode 54! In this episode we talk about antibiotic duration in bacteremia (BALANCE) and also antibiotic duration in Pseudomonas VAP (iDIAPASON).
BALANCE: https://t.co/rS7JkoA4PA
iDIAPASON: https://t.co/VRY6W97RGL
Listen anywhere: https://t.co/qPyhTM3p2C